Literature DB >> 2494912

Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice.

M Phillips1, G W Pugh, B L Deyoe.   

Abstract

A study was conducted to compare immunogenicity of a Brucella abortus lipopolysaccharide (LPS) and the duration of infection in 5 strains of mice. Mice of strains CBA/NJ, BALB/c, CD-1, C3H/HeN, and C3H/HeJ were allotted into 2 large groups (vaccinated with proteinase K-treated LPS or nonvaccinated) and 6 subgroups based on the intervals between challenge exposure to B abortus strain 2308 and the week the response data were obtained. Criteria used in comparing responses between the various strains of mice as well as between vaccinated and nonvaccinated mice were splenomegaly, colony-forming units (CFU) from spleens, and antibody titers. Responses were evaluated at 1, 2, 3, 5, 8, and 12 weeks after challenge exposure. Results indicated that all strains of mice became infected and maintained infection throughout the 12-week period, the percentages of mice infected were significantly (P less than 0.05) less in vaccinated mice for the first 5 weeks after challenge exposure, and there were no direct correlations between increased immunoglobulins (IgM and IgG titers) and reduction in CFU. Vaccinated mice of strains BALB/c, CD-1, C3H/HeN, and C3H/HeJ had increased titers when challenge exposed and also had significantly (P less than 0.05) smaller spleens and lower CFU. Vaccinated CBA/NJ mice did not have marked antibody titers. The overall results indicated that vaccination with LPS offers some initial protection against B abortus strain 2308 infection, but this protection disappears gradually and in various degrees in the 5 strains of mice studied.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494912

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence.

Authors:  J R McQuiston; R Vemulapalli; T J Inzana; G G Schurig; N Sriranganathan; D Fritzinger; T L Hadfield; R A Warren; L E Lindler; N Snellings; D Hoover; S M Halling; S M Boyle
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Impaired control of Brucella melitensis infection in Rag1-deficient mice.

Authors:  M J Izadjoo; Y Polotsky; M G Mense; A K Bhattacharjee; C M Paranavitana; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

Review 4.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

Review 5.  Laboratory animal models for brucellosis research.

Authors:  Teane M A Silva; Erica A Costa; Tatiane A Paixão; Renée M Tsolis; Renato L Santos
Journal:  J Biomed Biotechnol       Date:  2011-02-20

6.  Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection.

Authors:  Elías Barquero-Calvo; Esteban Chaves-Olarte; David S Weiss; Caterina Guzmán-Verri; Carlos Chacón-Díaz; Alexandra Rucavado; Ignacio Moriyón; Edgardo Moreno
Journal:  PLoS One       Date:  2007-07-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.